
OMC provided clarification on county-based license assignments and outlined specific criteria for reassignment flexibility.
OMC provided clarification on county-based license assignments and outlined specific criteria for reassignment flexibility.
Trump highlights hemp-derived CBD for senior healthcare, sparking discussion on cannabis reform, Medicare coverage, and the endocannabinoid system.
New statewide testing is coming to Colorado's regulated cannabis market. MED will sample products for contamination & verify potency claims.
California Governor Gavin Newsom signed AB 564, lowering CA's cannabis excise tax from 25% to 15% to help the legal market compete.
The 1906 cannabis brands and co-founder must pay $400,000 to Colorado and cease operations after failing to disclose health risks of "Midnight Drops."
Green Thumb Industries' RISE Dispensaries celebrates the launch of adult-use cannabis in Minnesota with new products and donations.
Our top five cannabis and hemp news this week: OCM fines NY lab, Congress halts rescheduling funding, Texas issues hemp order, NJ supports businesses with $15M in funding, and our latest podcast episode.
Governor Tim Walz signs new cannabis compact with Mille Lacs Band of Ojibwe, a move to regulate the market and support the start of Minnesota adult-use sales.
New Jersey’s new NJ LEAF program provides up to $1.5M in flexible funding to help cannabis businesses overcome capital access gaps.
New York's cannabis industry has grown to over $2 billion. The OCM's update shows market rebound and new support for equity applicants.
The FY26 CJS Appropriations Act includes Section 607, barring cannabis rescheduling. Advocates warn the Act threatens medical cannabis protections.
The OCM is taking action against Lexachrom Laboratory for regulatory failures and significant violations, jeopardizing consumer safety and market integrity.
The Texas Cannabis Policy Center and Texas Hemp Business Council both support Governor Abbott’s executive order on hemp regulations.
Our top five cannabis and hemp news this week: Nebraska’s medical cannabis battle, rescheduling debate, Thailand policy shifts, new medical cannabis research, and pricing trends.
Texas Governor Greg Abbott issues an executive order to regulate product sales, requiring ID checks and testing.
New York's legal cannabis sales top $2 billion, with 46 new licenses approved. The state is prioritizing social equity and new education panels.
Thailand's cannabis laws are evolving. A new Prime Minister brings hope for a discussion on legalizing cannabis.
Citing risks to children, health, and public safety, nine Congress members sent a letter to Attorney General Pam Bondi and President Donald Trump, opposing the rescheduling of cannabis.
The Maryland Comptroller reports nearly $18.4 million in Q2 cannabis tax revenue. The Central region, including Baltimore, generated the most income.
Nebraska’s cannabis commission approves restrictive rules, limiting patient access and business licenses.
Here, we bring you our top five recent articles covering federal hemp ban, an interview with Reginald Gaudino, PhD, the reintroduced MORE Act, Delaware cannabis sales and rezoning, and restricting intoxicating hemp-derived cannabinoids.
Delaware's first month of recreational marijuana sales was a success at over $7 million, but the veto of SB 75 shows an ongoing zoning debate.
The MORE Act, a federal cannabis reform bill, has recently been reintroduced to US Congress, with plans to deschedule cannabis and expunge convictions.
Two organizations with opposing views recently prepared letters to the Trump Administration on the anticipated action regarding cannabis reclassification.
A bipartisan group of state and territorial attorneys general have called for Congress to enact the SAFER Banking Act or similar legislation to help with cannabis banking in the industry.